Scope
NICE NG253 uses clinical assessment and setting-specific risk stratification to guide early care of suspected sepsis in people aged 16 or over. Its acute-care NEWS2 pathway excludes pregnancy and recent pregnancy, escalates for clinical concern or hypoperfusion, and links antibiotic timing, cautious fluid boluses and source control to the assessed risk.
Written by House with AI assistance · AI-assisted source check 29 October 2026.
This is House’s summary of the cited guidance. The source check is not an independent clinician review. Open the publication for complete recommendations, exceptions, evidence grades and later amendments.
Recognize sepsis without relying on fever
- Consider sepsis with possible infection even when symptoms are nonspecific or temperature is not raised. Take the person’s and carers’ concerns seriously, and assess new abnormalities of behaviour, circulation or breathing. [1]
- Record temperature, pulse, respiratory rate, blood pressure, consciousness and oxygen saturation; ask about urine output and look for a source requiring drainage. Interpret findings against baseline: absence of fever and normal blood pressure do not reliably exclude sepsis. [1]
- Suspect neutropenic sepsis when an unwell person has received systemic anticancer treatment within 30 days, or potentially neutropenia-producing immunosuppression. Refer immediately to secondary or tertiary care and use the dedicated neutropenic-sepsis pathway regardless of cause. [1]
Use the correct setting-specific risk pathway
- For people aged at least 16 who are not pregnant or recently pregnant, use NEWS2 in acute hospitals, acute mental-health settings and ambulances, alongside history, examination and underlying physiology. Community and custodial assessment uses the separate clinical risk criteria. [1]
- With suspected or confirmed infection, NEWS2 at least 7 suggests high risk, 5–6 medium risk, 1–4 low risk and 0 very low risk. A single parameter scoring 3 requires high-priority clinical review to decide the actual risk level; a low aggregate score does not overrule clinical concern. [1]
- Consider a higher risk category for mottled or ashen appearance, non-blanching petechiae or purpura, cyanosis, deterioration or failure to improve. Recalculate NEWS2 every 30 minutes at high risk, hourly at medium risk, every 4–6 hours at low risk, and with routine observations at very low risk; recalculate earlier for unexpected change. [1]
- Outside hospital, any community high-risk criterion requires immediate emergency transfer and pre-alert. For medium risk, establish a diagnosis and whether safe community treatment is possible; otherwise refer urgently. Ambulance crews should consider time-critical transfer for consecutive NEWS2 scores at least 5 or significant clinical concern. [1]
Treat high risk promptly and reassess
- In hospital, urgently assess high-risk patients, consider alternative diagnoses and obtain venous gas with glucose and lactate, cultures, blood count, inflammatory markers, renal and liver tests and clotting. The 2026 update says to consider procalcitonin testing. Take microbiological and blood samples before antimicrobials. [1]
- For high-risk sepsis, give broad-spectrum intravenous antibiotics within 1 hour of NEWS2 calculation at initial emergency-department assessment or ward deterioration. Account for treatment already given for this episode rather than automatically duplicating a pre-hospital dose. [1]
- For high risk, give an intravenous fluid bolus without delay and within 1 hour of identifying high risk, unless contraindicated. Use balanced isotonic crystalloid, or 0.9% saline when a balanced solution is unavailable. [1]
- For suspected sepsis in people aged 16 or over who need intravenous resuscitation, start with 250 mL, ideally over 10–15 minutes. Reassess after every bolus; give further 250 mL boluses only as needed, up to 1,000 mL including earlier fluids. If improvement remains inadequate after that amount, obtain senior advice. [1]
- Discuss vasopressors with critical care or the senior decision maker, including peripheral initiation if central access is unavailable. Agree appropriate escalation considering the person’s condition, advance plans and urgency. Peripheral use requires local drug, concentration and monitoring protocols, a visible line and surveillance for extravasation. [1]
- If a high-risk patient fails to respond within 1 hour of any intervention, ensure in-person senior review, refer to or discuss with critical care and inform the responsible consultant. [1]
Preserve safeguards around diagnostic observation
- At medium risk, obtain venous blood gas including glucose and lactate, blood cultures, blood count, CRP, renal and liver tests and clotting, consider procalcitonin and arrange a clinician competent in acute illness to review the patient and lactate within 1 hour. [1]
- Only after appropriate acute-clinician assessment of medium risk, consider deferring broad-spectrum antibiotics for up to 3 hours from the first NEWS2 at emergency assessment or ward deterioration to establish a more specific diagnosis, with senior discussion. Once antibiotics are chosen, do not delay them further. [1]
- For NEWS2 5–6 with one parameter scoring 3, manage as high risk if infection is the likely cause of that extreme value. Medium-risk patients with hypoperfusion, such as lactate above 2 mmol/L or acute kidney injury, must also follow the high-risk pathway; delay allowances do not apply after escalation. [1]
- At medium risk without hypoperfusion, consider intravenous fluid only after clinical assessment, using the same type-and-volume recommendations. Escalate for deterioration or lack of improvement. [1]
- At low risk, arrange practitioner review within 1 hour and tests when indicated. An acute-illness clinician may consider a diagnostic observation period up to 6 hours from the first NEWS2 at emergency-department assessment or ward deterioration before broad-spectrum antibiotics; give them without further delay once decided. NEWS2 3–4 with an infection-related single 3-point parameter requires medium- or high-risk management. [1]
- A NEWS2 score of 0 with infection still requires practitioner review, clinical judgement and repeat observations. For low or very low risk, reassess and escalate when the course warrants it; discharge advice should explain the diagnosis if known, warning signs and how to obtain help. [1]
Target infection, oxygen and recovery needs
- Use local source-specific antimicrobial guidance; for adults needing empirical intravenous treatment without a confirmed diagnosis, use the agreed formulary. When cultures or source clarification become available, review therapy and narrow the spectrum where appropriate. [1]
- For adults aged at least 18, target oxygen saturation 94–98%, or 88–92% when at risk of hypercapnic respiratory failure. Pulse-oximeter readings can be inaccurate, with overestimation reported in darker skin; interpret borderline values clinically. [1]
- Tailor source investigation to the history and examination; consider urine testing and chest radiography, then abdominal or pelvic imaging if no source is found. Involve surgery or interventional radiology early when source control is suitable and perform it as soon as possible after senior timing advice. [1]
- After sepsis, communicate the diagnosis to the patient, carers and primary-care team. Discuss recovery, possible longer-term problems, community needs and follow-up, including critical-care follow-up where relevant. [1]
Limitations and use
- This selected early-management summary is for the nonpregnant NEWS2 population aged 16 or over. It does not reproduce the complete community risk table, pregnancy/recent-pregnancy pathway, NEWS2 scoring chart, adolescent antibiotic and oxygen schedules, or a full intensive-care protocol.
- Antibiotic observation windows apply only after the specified clinical risk assessment and ongoing review. They must not delay treatment after high-risk escalation, a decision to prescribe, or recognition of neutropenic sepsis.
- Local antibiotic resistance, allergy, organ function and formulary determine regimen and dose. Peripheral vasopressor drug choices and doses require the local monitored-care protocol.
This summary is selective and does not reproduce every recommendation. Apply the source’s population, setting and eligibility criteria, together with clinical judgement and local policy.
Summary sources
- Suspected sepsis in people aged 16 or over: recognition, assessment and early management
Selected recommendation material consulted
Publication details
- Issuing organisation
- NICE
- First published
- 19 November 2025
- Publisher’s latest update
- 23 September 2026
- Resource type
- Clinical guideline · House clinical summary
- Source setting
- United Kingdom
The source check confirms publication details and the linked edition. It does not certify every recommendation or its suitability for an individual patient. Publisher access conditions may apply.